Board of Directors

William Park Chief Executive Officer

William "Bill" Park joined DeepDyve as chief executive officer in 2008. Prior to DeepDyve, Mr. Park served at Acxiom Corporation, a global leader in customer information management, where he led the company's Data, Digital, and Direct organization, a $225 million business unit. In this position, he oversaw all aspects of sales, services, development, and operations domestically and internationally, generating record revenues and profits. Prior to Acxiom, Mr. Park founded and served as chairman and CEO of Digital Impact, a leader in online direct marketing solutions for the Fortune 1000. He grew the company from inception through its initial public offering in 1999 and to its successful sale to Acxiom in 2005. Prior to founding Digital Impact in 1997, Mr. Park held numerous management positions at technology and enterprise software companies. He graduated from the University of Pennsylvania and earned an MBA degree from the Stanford University Graduate School of Business.

John Dorman Chairman

Mr. Dorman is retired as chairman, president and CEO of Digital Insight Corporation. Prior to joining Digital Insight, Mr. Dorman was senior vice president of the Oracle Corporation's Global Financial Services division where he was responsible for product development, services, and sales to banks and brokerage firms worldwide, generating $400 million in revenues. Previously, Mr. Dorman founded and served as chairman and CEO of Treasury Services Corporation, which was acquired by Oracle in 1997. Before founding Treasury Services Corporation in 1983, Mr. Dorman spent 11 years at Union Bank of California, where he progressed rapidly through a number of management positions, becoming treasurer of the bank from 1979 to 1983. Mr. Dorman earned a BA degree in business administration and philosophy from Occidental College and an MBA degree in finance from the University of Southern California. Mr. Dorman currently serves on the Board of Directors of Digital Insight Corporation, The Yosemite Fund, and the Center for Entrepreneurship and Engineering Management of the University of California at Santa Barbara. He was named Entrepreneur of the Year in the Greater Los Angeles Area by Ernst & Young in 2003 and was also named to the National Entrepreneur of the Year Hall of Fame.

Rafael Ortiz Board Member

Rafael Ortiz is the co-founder of NexTag, the leading comparison shopping website, where he served as vice president of marketing. The company sold a majority stake in 2007 at a $1.2 Billion valuation. He previously worked in marketing and sales roles at Apple and ROLM, and is the co-author of In Company of Giants (McGraw-Hill 1997). Rafael currently serves as a director of USA Cycling's Development Foundation and holds an MBA from Stanford University and a BA in economics from UC Santa Cruz.

Linda Sonntag Board Member

Dr Sonntag is a veteran of the Life Sciences and Healthcare industries and currently serves as advisor to a number of industry-related for-profit and not-for-profit boards, including Unistraw, the Life Sciences Advisory Board of Johnston Blakely & Company, LLC, the Advisory Board of Utah Ventures and the Health Technology Center, a non-profit research and education organization that provides strategic information and resources to healthcare organizations about the future impact of technology in healthcare delivery.

Most recently, Linda was Executive Chair of Cellgate, Inc. a company committed to developing innovative anti-proliferative drugs to target diseases characterized by uncontrolled cell division. Previously, Dr. Sonntag was a General Partner of Axiom Venture Partners, L.P., founded in April 1994 to invest primarily in medical/healthcare and media/communications areas. Dr. Sonntag was also CEO of SyStemix, Inc., (NASDAQ: STMX, now NYSE: NVS), and prior to SyStemix, Dr. Sonntag handled biotech investments as SVP with E.S. Jacobs & Co., consulted with Adler & Co., and had management positions at Agrigenetics, Biotechnology General (NASDAQ: SVNT) and Focus Technologies. She has a Ph.D. in biochemistry from the University of Witwatersrand in South Africa and has studied at the Harvard Business School and at MIT’s Alfred P. Sloan School of Management.